Endocrinologic and Metabolic Drugs Advisory Committee
September 26, 2002
Hilton Silver Spring
8727 Colesville Road, Silver Spring, MD
BL 103979, Fabrazyme™ (agalsidase beta) Genzyme Corporation
8:00 Call to Order
Conflict of Interest Statement
Welcome
8:15 Genzyme Presentation
9:45 CBER Presentation
10:45 Open Public Hearing
11:45 Lunch
1:00 Charge to the Committee
1:15 Discussion and Questions
5:00 Adjourn